ATCC, founded in 1925 and based in the United States, operates within the business services industry, specifically focusing on research and development. The company employs between 201 and 500 staff members and reported revenue of approximately $103.8 million. ATCC is recognized for its contributions to the field of diagnostic surveillance, particularly in relation to influenza. A recent white paper authored by a principal scientist at ATCC emphasizes the critical role of effective surveillance systems and diagnostic tools in monitoring and controlling influenza outbreaks, especially zoonotic strains such as avian influenza. The paper discusses the public health threats posed by various types of influenza viruses and underscores the importance of accurate diagnostic materials in facilitating outbreak detection and management. ATCC provides authenticated analytical reference materials that support the development of reliable diagnostic and surveillance tools, highlighting its commitment to addressing significant health risks associated with influenza and its economic implications.